The abridged version of how we built a one-of-a-kind contract research group...
Triclinic Labs was founded in 2009 by David E. Bugay, G. Patrick Stahly, Shawn C. Comella, and Scott L. Childs.The principals at Triclinic were the scientific and operations drivers behind the growth of SSCI, a solid-state contract laboratory, that was the industry's first. The principals' shared belief in the value of customer focus, scientific integrity, and innovation led to the decision to create new capabilities at Triclinic Labs after SSCI was acquired in 2006.
In 2009 we began with just an idea to create a unique organization committed to comprehensive solid-state analysis, novel analytical techniques and data interpretation, and a focus on the chemical intellectual property these services generate. Back then we had a handful of instruments and minimal lab space (see the picture below). We've grown considerably since and now occupy more than 18,000 square feet of custom-built wet and dry laboratory, office, and conference space.
Why we're different:
We've spent the last ten + years building Triclinic Labs into a highly responsive, unique, and innovative contract physical and analytical chemistry contract service lab. We've leveraged nearly three decades of solid-state experience to build a focused development lab. We're not trying to be all things to all people. One stop does not fit all. We don't have an army of low wage technicians cranking out data. We're the custom tailor in an off-the-rack industry. You get the attention your project deserves. We treat each project as unique, just like the molecule we work on.
We have a different culture here.
Despite not being a startup, we still operate like one. Everyone is empowered to do the right thing for our clients and we actually get back to you when you have a question. You can reach anyone in the organization. Our employee retention rate is nearly 100% over 10 years. That's our best statistic. It shows in the work our employees do for you.
We Communicate.
Our historic client repeat rate is 98.3%. We believe that statistic is partly due to our ongoing efforts to offer tailored services and unique offerings. Our clients tell us we set the bar in responsiveness, scientific results, and actionable interpretation - we'd like to demonstrate there's a difference in service providers to you as well. You won't have to wait to hear from us. Questions get timely answers. We don't have a complicated response process - you communicate with the scientists.
We Innovate.
Our internal R&D program has produced numerous innovations including:
- Novel techniques and approaches to solid-state screening and selection which have significantly increased the probability of finding new forms
- Innovative software tools for methods and analysis of materials improving the level of detection to higher sensitivity than previously reached
- Unique techniques for drug product imaging and mapping
- Novel variable temperature and humidity transmission X-ray powder diffraction stages
- Greater understanding of the structure of non-crystalline materials, lyophile water content, and nano materials
- Our experts have contributed to more pharmaceutical development milestones and legal matters than any other group of contract physical and analytical chemistry experts.
We Collaborate.
We'll treat your project as important. Because it is. We'll provide better data, faster - and give you guidance on what to do with that information. So you can solve your development needs and move your programs forward.
We'd like to earn your business...
Please contact any of our team members to arrange a free consultation or to request more info.Meet some of our team...
G. Patrick Stahly, Ph.D.
Founding Member
David E. Bugay, Ph.D.
Chief Scientific Officer
+1-765-588-5631 | |
+1-765-404-9017 | |
Email Dave Bugay | |
Download Dave's VCard | |
Dave's CV, Publications, Patents, and Lectures |
Aeri Park, Ph.D.
Chief Operating Officer
+1-765-588-.9538 | |
+1-765-426-7243 | |
Email Aeri Park | |
Download Aeri's VCard | |
Aeri's CV, Publications, Patents, and Lectures by Request |
Andy Gilkison, Ph.D.
Director, Analytical Method Development
+1-765-588-5634 | |
Email Andy Gilkison | |
Download Andy's VCard | |
Andy's CV, Publications, and Lectures by Request |
Stephan (Steef) Boerrigter, Ph.D.
Research Fellow
+1-765-588-5632 | |
Email Steef | |
Download Steef's VCard | |
Steef's CV, Publications, and Lectures by Request |
Byungsu Kwan, Ph.D.
Director, NMR Services
Dr. Kwon received his Ph.D. in Physical Chemistry from MIT. His areas of research during his Ph.D. involved the structure and dynamics of membrane proteins using solid-state NMR and biophysical techniques. After 2 years as a postdoc at MIT, Dr. Kwon joined Triclinic as Director of NMR services where he is contributing to identification of chemical compounds, structure elucidation, characterization of solid forms, determination concentration and potency, and patent prosecution and litigation support using liquid- and solid-state NMR. Dr. Kwon has not only gained a broad knowledge of NMR spectroscopy in both software and hardware, but also obtained significant experience in advanced solid-state NMR applications and was responsible for performing state-of-the-art MD simulations. In addition, Dr. Kwon has an extensive knowledge of solid-phase peptide synthesis (SPPS) and Native chemical ligation (NCL).
+1-765-588-5647 | |
Email Byungsu Kwon | |
Download Byungsu's VCard | |
Byungsu's CV, Publications, and Lectures by Request |
Nico Setiawan, Ph.D.
Senior Scientist
Dr. Nico Setiawan received his Ph.D. in Pharmaceutical Science from the University of Kentucky. Nico is an expert in the preformulation space of API development, including solid form screen and selection, solid-state and physicochemical characterization, crystallization process development, development of enabling formulation for poorly soluble compounds, and biorelevant dissolution method development for orally administered compounds. His research focuses on integrating properties of API and physiological barriers to deliver efficacious drug products. Dr. Setiawan has published papers in peer-reviewed journals and presented at national conferences. He is also an active reviewer of several peer-reviewed journals.
+1-765-422-5009 | |
Email Nico Setiawan | |
Download Nico's VCard | |
Nico's CV, Publications, and Lectures by Request |
Shawn Comella
Chief Executive Officer
+1-765-588-5624 | |
+1-765-337-4425 | |
Email Shawn Comella | |
Download Shawn's VCard | |
Shawn's CV, Publications, and Lectures by Request |